DOI QR코드

DOI QR Code

Controlled-Release Pelletized Dosage Forms Using the Extrusion-Spheronization Process

  • Rhee, Yun-Seok (School of Pharmacy, Sungkyunkwan University) ;
  • Lee, Jae-Hwi (College of Pharmacy, Chung-Ang University) ;
  • Lee, Beom-Jin (Bioavailability Control Laboratory, College of Pharmacy, Kangwon National University) ;
  • Park, Eun-Seok (School of Pharmacy, Sungkyunkwan University)
  • 투고 : 2010.08.17
  • 심사 : 2010.10.07
  • 발행 : 2010.12.20

초록

Pellets, which are multiple-unit dosage systems, have the several therapeutic advantages over single-unit dosage systems in oral drug delivery. This review focuses on the current status and explores extrusion-spheronization technique with special attention to controlled-release application of pellets including coated pellets for delayed release formulations, coated pellets for colon delivery, coated pellets for sustained drug delivery, sustained-release matrix pellets, pellets compressed into tablets, bioadhesive pellets, floating pellets, and pelletization with solubilization techniques.

키워드

참고문헌

  1. Abbaspour, M.R., Sadeghi, F., Afrasiabi Garekani, H., 2007. Thermal treating as a tool to produce plastic pellets based on Eudragit RS PO and RL PO aimed for tableting. Eur. J. Pharm. Biopharm. 67, 260-267. https://doi.org/10.1016/j.ejpb.2007.01.018
  2. Abdalla, A., Klein, S., Mader, K., 2008. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur. J. Pharm. Sci. 35, 457-464. https://doi.org/10.1016/j.ejps.2008.09.006
  3. Abdalla, A., Mader, K., 2007. Preparation and characterization of a self-emulsifying pellet formulation. Eur. J. Pharm. Biopharm. 66, 220-226. https://doi.org/10.1016/j.ejpb.2006.11.015
  4. Awad, G.A.S., Charrueau, C.A.A., Allain, P., Chaumeil, J.C., 2002. Formulation and evaluation of bioadhesive pellets containing different carbomers made by extrusion-spheronization. STP Pharm. Sci. 12, 157-162.
  5. Bendas, E.R., Ayres, J.W., 2008. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data. Eur. J. Pharm. Biopharm. 69, 977-985. https://doi.org/10.1016/j.ejpb.2008.02.019
  6. Bendas, E.R., Christensen, J.M., Ayres, J.W., 2010. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets. Drug Dev. Ind. Pharm. 36, 393-404. https://doi.org/10.3109/03639040903213717
  7. Bodmeier, R., 1997. Tableting of coated pellets. Eur. J. Pharm. Biopharm. 43, 1-8. https://doi.org/10.1016/S0939-6411(96)00028-8
  8. Brachkova, M.I., Duarte, A., Pinto, J.F., 2009. Evaluation of the viability of Lactobacillus spp. after the production of different solid dosage forms. J. Pharm. Sci. 98, 3329-3339. https://doi.org/10.1002/jps.21609
  9. Bruce, L.D., Petereit, H.U., Beckert, T., McGinity, J.W., 2003. Properties of enteric coated sodium valproate pellets. Int. J. Pharm. 264, 85-96. https://doi.org/10.1016/S0378-5173(03)00392-2
  10. Chi, N., Guo, J.H., Zhang, Y., Zhang, W., Tang, X., 2010. An oral controlled release system for ambroxol hydrochloride containing a wax and a water insoluble polymer. Pharm. Dev. Technol. 15, 97-104. https://doi.org/10.3109/10837450903013576
  11. Chiou, W.L., Riegelman, S., 1971. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60, 1281-1302. https://doi.org/10.1002/jps.2600600902
  12. Chivate, A.A., Poddar, S.S., 2008. Designing, optimisation & characterization of sustained release matrix pellets prepared by extrusion spheronization containing mixture of proteolytic enzymes. Curr. Drug Deliv. 5, 265-274. https://doi.org/10.2174/156720108785914989
  13. Chuong, M.C., Christensen, J.M., Ayres, J.W., 2009. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis. Pharm. Dev. Technol. 14, 116-125.
  14. Dashevsky, A., Kolter, K., Bodmeier, R., 2004. Compression of pellets coated with various aqueous polymer dispersions. Int. J. Pharm. 279, 19-26. https://doi.org/10.1016/j.ijpharm.2004.03.019
  15. Debunne, A., Vervaet, C., Remon, J.P., 2002. Development and in vitro evaluation of an enteric-coated multiparticulate drug delivery system for the administration of piroxicam to dogs. Eur. J. Pharm. Biopharm. 54, 343-348. https://doi.org/10.1016/S0939-6411(02)00117-0
  16. el-Mahdi, I.M., Deasy, P.B., 2000. Tableting of coated ketoprofen pellets. J. Microencapsul. 17, 133-144. https://doi.org/10.1080/026520400288373
  17. Elchidana, P.A., Deshpande, S.G., 1999. Microporous membrane drug delivery system for indomethacin. J. Control. Release 59, 279-285. https://doi.org/10.1016/S0168-3659(98)00162-X
  18. Fekete, R., Zelko, R., Marton, S., Racz, I., 1998. Effect of the formulation parameters on the characteristics of pellets. Drug Dev Ind Pharm 24, 1073-1076. https://doi.org/10.3109/03639049809089951
  19. Freire, C., Podczeck, F., Veiga, F., Sousa, J., 2010. Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease intended for colon-specific drug delivery. Drug Dev. Ind. Pharm. 36, 161-172. https://doi.org/10.3109/03639040903124617
  20. Ghaffari, A., Avadi, M.R., Moghimi, H.R., Oskoui, M., Bayati, K., Rafiee-Tehrani, M., 2008. Mechanistic analysis of drug release from theophylline pellets coated by films containing pectin, chitosan and Eudragit RS. Drug Dev. Ind. Pharm. 34, 390-402. https://doi.org/10.1080/03639040701662453
  21. Ghosh, P.K., Murthy, R.S., 2006. Microemulsions: a potential drug delivery system. Current Drug Delivery 3, 167-180. https://doi.org/10.2174/156720106776359168
  22. Gursoy, R.N., Benita, S., 2004. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine & Pharmacotherapy 58, 173-182. https://doi.org/10.1016/j.biopha.2004.02.001
  23. Huang, Y.T., Tsai, T.R., Cheng, C.J., Cham, T.M., Lai, T.F., Chuo, W.H., 2007. Formulation design of a highly hygroscopic drug (pyridostigmine bromide) for its hygroscopic character improvement and investigation of in vitro/in vivo dissolution properties. Drug Dev. Ind. Pharm. 33, 403-416. https://doi.org/10.1080/03639040601031890
  24. Iosio, T., Voinovich, D., Grassi, M., Pinto, J.F., Perissutti, B., Zacchigna, M., Quintavalle, U., Serdoz, F., 2008. Bi-layered selfemulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption. Eur. J. Pharm. Biopharm. 69, 686-697. https://doi.org/10.1016/j.ejpb.2007.11.014
  25. Jachowicz, R., Nurnberg, E., Pieszczek, B., Kluczykowska, B., Maciejewska, A., 2000. Solid dispersion of ketoprofen in pellets. Int. J. Pharm. 206, 13-21. https://doi.org/10.1016/S0378-5173(00)00437-3
  26. Karrout, Y., Neut, C., Wils, D., Siepmann, F., Deremaux, L., Flament, M.P., Dubreuil, L., Desreumaux, P., Siepmann, J., 2009. Novel polymeric film coatings for colon targeting: Drug release from coated pellets. Eur. J. Pharm. Sci. 37, 427-433. https://doi.org/10.1016/j.ejps.2009.03.014
  27. Kibria, G., Islam, K.M., Jalil, R.U., 2009. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer. Pak. J. Pharm. Sci. 22, 36-43.
  28. Kilor, V.A., Sapkal, N.P., Awari, J.G., Shewale, B.D., 2010. Development and characterization of enteric-coated immediaterelease pellets of aceclofenac by extrusion/spheronization technique using kappa-carrageenan as a pelletizing agent. AAPS PharmSciTech 11, 336-343. https://doi.org/10.1208/s12249-010-9389-9
  29. Kojima, M., Nakagami, H., 2002. Development of controlled release matrix pellets by annealing with micronized waterinsoluble or enteric polymers. J. Control. Release 82, 335-343. https://doi.org/10.1016/S0168-3659(02)00143-8
  30. Krogars, K., Heinamaki, J., Vesalahti, J., Marvola, M., Antikainen, O., Yliruusi, J., 2000. Extrusion-spheronization of pH-sensitive polymeric matrix pellets for possible colonic drug delivery. Int. J. Pharm. 199, 187-194. https://doi.org/10.1016/S0378-5173(00)00382-3
  31. Liu, Y., Schwartz, J.B., Schnaare, R.L., 2003. A multimechanistic drug release approach in a bead dosage form and in vitro predictions. Pharm. Dev. Technol. 8, 163-173. https://doi.org/10.1081/PDT-120018486
  32. Mallipeddi, R., Saripella, K.K., Neau, S.H., 2010. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization. Int. J. Pharm. 385, 53-65. https://doi.org/10.1016/j.ijpharm.2009.10.028
  33. Mayo-Pedrosa, M., Alvarez-Lorenzo, C., Lacik, I., Martinez-Pacheco, R., Concheiro, A., 2007. Sustained release pellets based on poly(N-isopropyl acrylamide): matrix and in situ photopolymerization-coated systems. J. Pharm. Sci. 96, 93-105. https://doi.org/10.1002/jps.20708
  34. Mehta, K.A., Kislalioglu, M.S., Phuapradit, W., Malick, A.W., Shah, N.H., 2000. Effect of formulation and process variables on porosity parameters and release rates from a multi unit erosion matrix of a poorly soluble drug. J. Control. Release 63, 201-211. https://doi.org/10.1016/S0168-3659(99)00193-5
  35. Mehta, K.A., Kislalioglu, M.S., Phuapradit, W., Malick, A.W., Shah, N.H., 2001. Release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix. Int. J. Pharm. 213, 7-12. https://doi.org/10.1016/S0378-5173(00)00594-9
  36. Mehta, K.A., Kislalioglu, M.S., Phuapradit, W., Malick, A.W., Shah, N.H., 2002. Multi-unit controlled release systems of nifedipine and nifedipine:pluronic F-68 solid dispersions: characterization of release mechanisms. Drug Dev. Ind. Pharm. 28, 275-285. https://doi.org/10.1081/DDC-120002843
  37. Mezreb, N., Charrueau, C., Boy, P., Allain, P., Chaumeil, J.C., 2004. Production of Carbopol 974P and Carbopol 971P pellets by extrusion-spheronization: optimization of the processing parameters and water content. Drug Dev. Ind. Pharm. 30, 481-490. https://doi.org/10.1081/DDC-120037476
  38. Montousse, C., Pruvost, M., Rodriguez, F., Brossard, C., 1999. Extrusion-spheronization manufacture of Gelucire matrix beads. Drug Dev. Ind. Pharm. 25, 75-80. https://doi.org/10.1081/DDC-100102144
  39. Newton, M., Petersson, J., Podczeck, F., Clarke, A., Booth, S., 2001. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J. Pharm. Sci. 90, 987-995. https://doi.org/10.1002/jps.1051
  40. Panchagnula, R., Gupta, A., Kandavilli, S., Varma, M.V., 2006. High-throughput evaluation of non-swellable controlled release matrix tablets. Drug Dev. Ind. Pharm. 32, 669-675. https://doi.org/10.1080/03639040600683485
  41. Pieszczek, B., Jachowicz, R., 2010. The effect of physico-chemical properties of the drug on the pharmaceutical availability of piroxicam from pellets. Pharm. Dev. Technol. 15, 241-248. https://doi.org/10.3109/10837450903110745
  42. Pund, S., Joshi, A., Vasu, K., Nivsarkar, M., Shishoo, C., 2010. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets. Int. J. Pharm. 388, 64-72. https://doi.org/10.1016/j.ijpharm.2009.12.034
  43. Rahman, M.A., Ahuja, A., Baboota, S., Bhavna, Bali, V., Saigal, N., Ali, J., 2009. Recent advances in pelletization technique for oral drug delivery: a review. Curr. Drug Deliv. 6, 122-129. https://doi.org/10.2174/156720109787048339
  44. Sawicki, W., Lunio, R., 2005. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D. Eur. J. Pharm. Biopharm. 60, 153-158. https://doi.org/10.1016/j.ejpb.2004.11.003
  45. Scala-Bertola, J., Gajdziok, J., Rabiskova, M., Bonneaux, F., Lecompte, T., Sapin, A., Maincent, P., 2009. Pellets for oral administration of low-molecular-weight heparin. Drug Dev. Ind. Pharm. 35, 1503-1510. https://doi.org/10.3109/03639040903037207
  46. Serratoni, M., Newton, M., Booth, S., Clarke, A., 2007. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Eur. J. Pharm. Biopharm. 65, 94-98. https://doi.org/10.1016/j.ejpb.2006.07.011
  47. Shavi, G.V., Nayak, U., Averineni, R.K., Arumugam, K., Meka, S.R., Nayanabhirama, U., Sureshwar, P., 2009. Multiparticulate drug delivery system of aceclofenac: development and in vitro studies. Drug Dev. Ind. Pharm. 35, 252-258. https://doi.org/10.1080/03639040802277680
  48. Siepmann, F., Muschert, S., Flament, M.P., Leterme, P., Gayot, A., Siepmann, J., 2006. Controlled drug release from Gelucirebased matrix pellets: experiment and theory. Int. J. Pharm. 317, 136-143. https://doi.org/10.1016/j.ijpharm.2006.03.006
  49. Sinha, V.R., Agrawal, M.K., Agarwal, A., Singh, G., Ghai, D., 2009. Extrusion-spheronization: process variables and characterization. Crit. Rev. Ther. Drug Carrier Syst. 26, 275-331. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v26.i3.20
  50. Sungthongjeen, S., Paeratakul, O., Limmatvapirat, S., Puttipipatkhachorn, S., 2006. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique. Int. J. Pharm. 324, 136-143. https://doi.org/10.1016/j.ijpharm.2006.06.002
  51. Talegaonkar, S., Azeem, A., Ahmad, F.J., Khar, R.K., Pathan, S.A., Khan, Z.I., 2008. Microemulsions: a novel approach to enhanced drug delivery. Recent Patents on Drug Delivery & Formulation 2, 238-257. https://doi.org/10.2174/187221108786241679
  52. Tian, L., Zhang, Y., Tang, X., 2008. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs. Drug Dev. Ind. Pharm. 34, 569-576. https://doi.org/10.1080/03639040701831702
  53. Trivedi, N.R., Rajan, M.G., Johnson, J.R., Shukla, A.J., 2007. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Crit. Rev. Ther. Drug Carrier Syst. 24, 1-40. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v24.i1.10
  54. Tuleu, C., Newton, M., Rose, J., Euler, D., Saklatvala, R., Clarke, A., Booth, S., 2004. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J. Pharm. Sci. 93, 1495-1502. https://doi.org/10.1002/jps.20068
  55. Vergote, G.J., Kiekens, F., Vervaet, C., Remon, J.P., 2002. Wax beads as cushioning agents during the compression of coated diltiazem pellets. Eur. J. Pharm. Sci. 17, 145-151. https://doi.org/10.1016/S0928-0987(02)00164-1
  56. Wagner, K.G., Krumme, M., Schmidt, P.C., 2000. Pellet-containing tablets examination of distribution and deformation behaviour. STP Pharm. Sci. 10, 327-334.
  57. Wang, L., Wang, J., Lin, X., Tang, X., 2010a. Preparation and in vitro evaluation of gliclazide sustained-release matrix pellets: formulation and storage stability. Drug Dev. Ind. Pharm. 36, 814-822. https://doi.org/10.3109/03639040903520967
  58. Wang, Z., Sun, J., Wang, Y., Liu, X., Liu, Y., Fu, Q., Meng, P., He, Z., 2010b. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int. J. Pharm. 383, 1-6. https://doi.org/10.1016/j.ijpharm.2009.08.014
  59. Williams, R.O., 3rd, Liu, J., 2000. Influence of processing and curing conditions on beads coated with an aqueous dispersion of cellulose acetate phthalate. Eur. J. Pharm. Biopharm. 49, 243-252. https://doi.org/10.1016/S0939-6411(00)00065-5
  60. Wiwattanapatapee, R., Pengnoo, A., Kanjanamaneesathian, M., Matchavanich, W., Nilratana, L., Jantharangsri, A., 2004. Floating pellets containing bacterial antagonist for control sheath blight of rice: formulations, viability and bacterial release studies. J. Control. Release 95, 455-462. https://doi.org/10.1016/j.jconrel.2003.12.024
  61. Zeeshan, F., Bukhari, N.I., 2010. Development and evaluation of a novel modified-release pellet-based tablet system for the delivery of loratadine and pseudoephedrine hydrochloride as model drugs. AAPS PharmSciTech 11, 910-916. https://doi.org/10.1208/s12249-010-9456-2
  62. Zeeshan, F., Peh, K.K., Tan, Y.T., 2009. Exploring the potential of a highly compressible microcrystalline cellulose as novel tabletting excipient in the compaction of extended-release coated pellets containing an extremely water-soluble model drug. AAPS PharmSciTech 10, 850-857. https://doi.org/10.1208/s12249-009-9278-2
  63. Zhang, X., Tang, X., Yang, R., 2009. Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets. Drug Dev. Ind. Pharm. 35, 26-33. https://doi.org/10.1080/03639040802144203

피인용 문헌

  1. Approaches to developing fast release pellets via wet extrusion-spheronization pp.1097-9867, 2018, https://doi.org/10.1080/10837450.2016.1265556